# Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)

> **NCT00696878** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 682 (actual)

## Conditions studied

- In Vitro Fertilization

## Interventions

- **DRUG:** Corifollitropin alfa
- **BIOLOGICAL:** FSH
- **BIOLOGICAL:** GnRH antagonist
- **BIOLOGICAL:** (rec)hCG
- **DRUG:** Progesterone

## Key facts

- **NCT ID:** NCT00696878
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-09-26
- **Primary completion:** 2009-02-17
- **Final completion:** 2009-05-15
- **Target enrollment:** 682 (ACTUAL)
- **Last updated:** 2024-06-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00696878

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00696878, "Corifollitropin Alfa in Participants Undergoing Repeated Controlled Ovarian Stimulation (COS) Cycles Using a Multiple Dose Gonadatropin Releasing Hormone (GnRH) Antagonist Protocol (Study 38825)(P05714)". Retrieved via AI Analytics 2026-09-07 from https://api.ai-analytics.org/clinical/NCT00696878. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*